Pfizer $10B Deal to Target Cancer

Pfizer makes a $10 billion deal to expand its cancer lineup and its footprint in an area as known as a precision medicine. Meg Tirrell reports.

This entry was posted in Biotech & Pharmaceuticals, Mergers & Acquisitions, NBR Show Clips. Bookmark the permalink.

Leave a Reply